This inventor holds 16 USPTO granted patents and 2 published patent applications and 12 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc.. Active years: 2000-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (2000)
- Nishinomiya, JP (2005 - 2006)
- Osaka, JP (2009)
- Fujisawa, JP (2017)
- Kanagawa, JP (2019 - 2023)
Company Filing History:
15 out of 1,226 
1 out of 1,858 
Years Active: 2000-2025
Of course! Here's the article about the inventor Masaki Ogino:
Title: Unveiling the Innovative Work of Masaki Ogino in Kanagawa, JP
Introduction:
Masaki Ogino, a distinguished inventor based in Kanagawa, JP, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents. With a total of 15 patents to his name, Ogino's work has garnered attention for its potential in treating a variety of disorders and conditions.
Latest Patents:
His latest patents showcase his ingenuity in developing novel compounds with therapeutic potential. One such patent is for a heterocyclic compound designed to target an NMDA receptor containing the NR2B subunit. This compound holds promise as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia, and more. Another patent highlights a heterocyclic compound with orexin type 2 receptor agonist activity, offering new possibilities for the prophylaxis or treatment of narcolepsy.
Career Highlights:
Throughout his career, Masaki Ogino has been associated with reputable companies in the pharmaceutical industry. Notably, he has worked at Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His tenure at these organizations has provided him with a conducive environment to pursue his innovative research and development initiatives.
Collaborations:
In his professional journey, Masaki Ogino has collaborated with esteemed colleagues such as Eiji Kimura and Tatsuki Koike. Together, they have synergized their expertise to advance the field of pharmaceuticals and bring forth groundbreaking solutions to complex medical challenges.
Conclusion:
In conclusion, Masaki Ogino's inventive spirit and dedication to scientific advancement have solidified his position as a trailblazer in the realm of pharmaceutical innovations. His patents and collaborative efforts stand as a testament to his commitment to creating impactful solutions for improving human health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile